BioSpace News Archive

Egypt has announced its plans to establish a map of the Egyptian human genome and enter the world of precision medicine; the Egyptian President Abdel Fattah El Sisi has been briefed on the development of the project by Prime Minister Mustafa Mabdouli and Minister of Higher Education Khaled Abdel Ghaffar.

XBiotech announced that the FDA has granted permission to commence clinical trials with its novel drug candidate for treating patients with pancreatic cancer.

ERS Genomics Limited and NUVISAN Innovation Campus Berlin GmbH announced a non-exclusive license agreement granting NUVISAN ICB access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

RETINA-AI Health Inc. has been awarded a U.S. patent on its Artificial Intelligence systems for autonomous detection of eye diseases from images.

RadNet, Inc., announced that its subsidiary DeepHealth, a leading developer of artificial intelligence for mammography interpretation, has received FDA clearance for its mammography triage software Saige-Q.

NDA submission includes both pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease indications

Aerie Pharmaceuticals, Inc. announced that Roclanda® 50 micrograms/ml + 200 micrograms/ml Eye Drops, Solution has received marketing authorisation from the Medicines and Healthcare Products Regulatory Agency in Great Britain.

Karam has spent his career driving consumer businesses across multiple geographies and cultures, including scaling direct-to-consumer operations across digital, social, and traditional marketing platforms, as well as launching and scaling product innovation.

CRH Medical Corp.'s securityholders approved the acquisition of CRH by a subsidiary of WELL Health at the special meeting of CRH securityholders on Friday April 16, 2021 . The transaction is expected to be completed on or about April 22, 2021 and represents WELL’s largest acquisition to date with a total transaction value of approximately US$369.2 million .

GATC Health , an innovative technology company focused on whole genome testing and Predictive Multiomics™, today announced that it has granted an exclusive license for its diabetes platform to GATC DB Care Corp. GATC DB Care was formed specifically to continue development and productization of the GATC Health diabetes platform